In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases. Alzforum, 19 Nov 2021 Sala A, Caminiti SP, Presotto L, Pilotto A, Liguori C, Chiaravalloti A, Garibotto V, Frisoni GB, D'Amelio M, Paghera B…